Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1996
12/31/1996US5589154 Diagnosing presence of b-amyloid peptide
12/31/1996CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella
12/28/1996CA2178684A1 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy
12/27/1996WO1996041887A1 Dnase-active protein
12/27/1996WO1996041881A1 Type f botulinum toxin and use thereof
12/27/1996WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby
12/27/1996WO1996041879A1 Camp factor of streptococcus uberis
12/27/1996WO1996041877A2 Malarial pre-erythrocytic stage polypeptide molecules
12/27/1996WO1996041874A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
12/27/1996WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996WO1996041523A1 Fgf9 as a specific ligand for fgfr3
12/27/1996EP0750041A2 HIV-2 nucleotide sequences
12/27/1996EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase
12/27/1996EP0749981A1 Monoclonal antibody
12/27/1996EP0749488A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
12/27/1996EP0749487A1 Cell surface protein and effector cell bonding reagent
12/27/1996EP0749486A1 Diagnostic skin test for tuberculosis
12/27/1996EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION
12/27/1996EP0749481A1 Humanized monoclonal antibodies against human interleukin-4
12/27/1996EP0749445A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
12/27/1996EP0749439A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof
12/27/1996EP0749325A1 Bispecific molecules having clinical utilities
12/27/1996EP0749323A1 Methods for modulating t cell unresponsiveness
12/27/1996EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS
12/27/1996EP0749321A1 Active immunization using a siderophore receptor protein
12/27/1996EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent
12/27/1996EP0749319A1 Immortalized cells and uses therefor
12/27/1996EP0749315A1 Induction of anti-tumor cytotoxic t lymphocytes in humans using synthetic peptide epitopes
12/27/1996EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF
12/27/1996EP0633784B1 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
12/27/1996EP0625190B1 New bacterium causing poultry disease and vaccine derived thereof
12/27/1996EP0332651B2 Method of isolating ca 125 antigen
12/27/1996CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby
12/27/1996CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996CA2221029A1 Malarial pre-erythrocytic stage polypeptide molecules
12/25/1996CN1138865A Peptides and methods against psoriasis
12/25/1996CN1138485A Use and prepn. of "Xinchengyi" virus
12/25/1996CN1138484A 抗癌疫苗 Anti-cancer vaccine
12/24/1996US5587311 DNA encoding a cell membrane glycoprotein of a tick gut
12/24/1996US5587306 Dna sequences
12/24/1996US5587305 Pasteurella haemolytica transformants
12/24/1996US5587291 Method for the determination of plasmin α2 -antiplasmin complexes and the use of this method as a mean of determining changes in the fibrinolytic system
12/24/1996US5587289 Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof
12/24/1996US5587166 Killed whole cells of pasteurella hemolytica grown under iron-restriction conditions in vitro, adjuvant
12/24/1996US5587164 Vaccine for protection against porcine reproductive and respiratory disease
12/24/1996US5587161 Prodrugs for antibody directed enzyme prodrug therapy
12/19/1996WO1996041179A1 Expression system for non-secretor genes
12/19/1996WO1996041171A1 Methods and articles of manufacture for diagnosis of mycobacterial infection
12/19/1996WO1996040957A1 Recombinant feline immunodeficiency vaccines produced in baculovirus
12/19/1996WO1996040956A1 Recombinant feline immunodeficiency vaccines produced in baculovirus
12/19/1996WO1996040953A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040947A1 Recombinant bacterial system with environmentally limited viability
12/19/1996WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines
12/19/1996WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses
12/19/1996WO1996040943A1 Use of gram-positive bacteria to express recombinant proteins
12/19/1996WO1996040941A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system
12/19/1996WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996WO1996040933A1 Infectious dengue 2 virus pdk-53 as quadravalent vaccine
12/19/1996WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus
12/19/1996WO1996040930A1 Mutants of streptococcal toxin a and methods of use
12/19/1996WO1996040929A2 Transferrin receptor genes
12/19/1996WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996WO1996040927A1 Isospora suis vaccine
12/19/1996WO1996040926A2 Detection of cryptosporidium parvum
12/19/1996WO1996040923A1 Macrophage derived chemokine and chemokine analogs
12/19/1996WO1996040921A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
12/19/1996WO1996040916A1 Icam-4 materials and methods
12/19/1996WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040893A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
12/19/1996WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION
12/19/1996WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996WO1996040880A1 Recombinant fowlpox viruses and uses thereof
12/19/1996WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
12/19/1996WO1996040795A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
12/19/1996WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
12/19/1996WO1996040788A1 Anti-allergy bispecific molecules
12/19/1996WO1996040777A2 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996WO1996040764A2 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040755A1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine
12/19/1996WO1996040731A1 Pegylated modified proteins
12/19/1996WO1996040718A1 Expression of lipoproteins
12/19/1996WO1996040663A1 Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
12/19/1996WO1996040642A1 Carbamazepine hydrazides useful in immunoassays
12/19/1996WO1996040502A1 Improved methods for the manufacture of magnetically responsive particles
12/19/1996WO1996040294A1 Hiv-1 prophylactic composition and method
12/19/1996WO1996040290A1 Immunological combination compositions and methods
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996WO1996040254A1 Polyphosphazene polyelectrolyte immunoadjuvants
12/19/1996WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996WO1996040250A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996WO1996040246A1 Treatment of t cell mediated autoimmune disorders
12/19/1996WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site
12/19/1996WO1996040244A1 Antibodies to porcine cd34 positive cells and uses therefor
12/19/1996WO1996040243A1 Liposomes containing human immunodeficiency virus glycoprotein and methods for use thereof
1 ... 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 ... 1823